Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07571928
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive AzoospermiaMartin Blomberg JensenNot Yet RecruitingPhase 1
NCT07571928Not Yet Recruiting
Phase 1
A Novel Aromatase Inhibitor, Leflutrozole, for Treatment of Non-Obstructive Azoo...Martin Blomberg Jensen
NCT07570264
LEXURE for Post-Stroke Aphasia: A Randomized, Evaluator-Blinded, Confirmatory TrialNunaps IncRecruitingNot Applicable
NCT07570264Recruiting
Not Applicable
LEXURE for Post-Stroke Aphasia: A Randomized, Evaluator-Blinded, Confirmatory Tr...Nunaps Inc
NCT07571395
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz AdriennNot Yet Recruiting
NCT07571395Not Yet Recruiting
—
Median Nerve Electromyography to Monitor Intraoperative Neuromuscular FunctionPongrácz Adrienn
NCT07570797
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07570797Not Yet Recruiting
Not Applicable
Mentor-Supported Digital Literacy TrainingErzincan Binali Yildirim...
NCT07571512
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Knee Arthroplasty for the Study of Innovative Solutions in the Treatment of Joint and Ligament PathologiesStefano ZaffagniniCompleted
NCT07571512Completed
—
In Vitro Microstructural and Mechanical Analysis of Waste Material From Total Kn...Stefano Zaffagnini
NCT07569887
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocognitive Disorders in Patients With Unruptured Arteriovenous Malformations Before and After Surgical TreatmentUniversity Hospital, MontpellierNot Yet RecruitingNot Applicable
NCT07569887Not Yet Recruiting
Not Applicable
Exploratory Study of Cerebral Perfusion and Metabolic Alterations and Neurocogni...University Hospital, Mont...
NCT07570368
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to Enhance Neoadjuvant Chemotherapy Response in Locally Advanced Breast CancerUniversitas AirlanggaNot Yet RecruitingNot Applicable
NCT07570368Not Yet Recruiting
Not Applicable
Targeting Stress-Driven Inflammatory and Angiogenic Pathways With Brief ACT to E...Universitas Airlangga
NCT07569926
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical RecurrenceBlue Earth DiagnosticsNot Yet RecruitingPhase 4
NCT07569926Not Yet Recruiting
Phase 4
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Managemen...Blue Earth Diagnostics
NCT07571707
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing General AnesthesiaUdayana UniversityRecruitingNot Applicable
NCT07571707Recruiting
Not Applicable
Effect of Lollipop on Emergence Delirium in Pediatric Patients Undergoing Genera...Udayana University
NCT07571668
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07571668Not Yet Recruiting
Not Applicable
Effects of Robotic Hand Therapy on Hand Function and Dexterity in Cerebral PalsyRiphah International Univ...
NCT07571070
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Amateur BoxersFederal University of VicosaCompletedNot Applicable
NCT07571070Completed
Not Applicable
High-Intensity Intermittent Training and Sport-Specific Performance in Youth Ama...Federal University of Vic...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07570862
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisFate TherapeuticsNot Yet RecruitingPhase 2
NCT07570862Not Yet Recruiting
Phase 2
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Neph...Fate Therapeutics
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07570147
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Ascending Doses of ABBV-1451 Infusions and Injections in Healthy Adult ParticipantsAbbVieNot Yet RecruitingPhase 1
NCT07570147Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Asc...AbbVie
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07569042
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed GlioblastomaNovelwise Pharmaceutical CorporationRecruitingPhase 1
NCT07569042Recruiting
Phase 1
A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Ne...Novelwise Pharmaceutical...
NCT07569367
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia SpectrumBioSensicsNot Yet Recruiting
NCT07569367Not Yet Recruiting
—
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotem...BioSensics
NCT07571551
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell CarcinomaJinling Hospital, ChinaNot Yet RecruitingPhase 2
NCT07571551Not Yet Recruiting
Phase 2
Perioperative Trial With IO/TKI for Multi-stage Clear Cell Renal Cell CarcinomaJinling Hospital, China
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Completed3 (15%)
not_applicable9 (45%)
Not Specified4 (20%)
Phase 13 (15%)
Phase 23 (15%)
Phase 41 (5%)